Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

December 2, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

January 1, 2015

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

Given subcutaneously

BIOLOGICAL

pegfilgrastim

Given subcutaneously

BIOLOGICAL

rituximab

Given IV

DRUG

cyclophosphamide

Given IV

DRUG

liposome-encapsulated doxorubicin citrate

Given IV

DRUG

prednisone

Given orally

DRUG

vincristine sulfate

Given IV

Trial Locations (1)

33076

Institut Bergonie, Bordeaux

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

lead

Institut Bergonié

OTHER